Scratching the (cell) surface: Cytokine engineering for improved ligand/receptor trafficking dynamics

Chemistry and Biology

Volumn 5, Issue 10, 1998, Pages

  Lauffenburger, Douglas A ^a   Fallon, Eric M ^a   Haugh, Jason M ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032193334     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(98)90110-7     Document Type: Review

References (58)

1. Mizrahi, A. & Lazar, A. (1988). Media for cultivation of animal cells: an overview. Cytotechnology 1, 199-214.
2. Wolfe, R.W. (1993). Media for cell culture. In Biotechnology, Vol. 3. (G. Stephanopoulos, ed.), pp. 141-156, VCH Publishers, New York.
3. Zandstra, P.W., Petzer, A.L., Eaves, C.J. & Piret, J.M. (1997). Cellular determinants affecting the rate of cytokine depletion in cultures of human hematopoietic cells. Biotech. Bioeng. 12, 909-914.
4. Nimmi, M.E. (1997). Polypeptide growth factors: targeted delivery systems. Biomaterials 18, 1201-1225.
5. Kovacs, J.A., et al., & Lane, H.C. (1995). Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection: a preliminary study. N. Engl. J. Med. 332, 567-575.
6. Jacobson, E.L., Pilaro, F. & Smith, K.A. (1996). Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity. Proc. Natl Acad. Sci. USA 93, 10405-10410.
7. Hartmann, G., et al., & Gherardi, E. (1997). Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Curr. Biol. 8, 125-134.
8. Katre, N.V. (1993). The conjugation of proteins with polyethylene glycol and other polymers: altering properties of proteins to enhance their therapeutic potential. Adv. Drug Delivery Rev. 10, 91-114.
9. Brenner, B.M., Ichikawa, I. & Deen, W.M. (1981). Glomerular filtration. In The Kidney, Vol. 1. (B.M. Brenner & F.C. Rector, eds), pp. 289-327, W.B. Saunders Co., Philadelphia.
10. Trowbridge, I.S., Collawn, J.F. & Hopkins, C.R. (1993). Signal-dependent membrane protein trafficking in the endocytic pathway. Annu. Rev. Cell Biol. 9, 129-161.
11. Mellman, I. (1996). Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 12, 575-625.
12. Lund, K.A., Opresko, L.K., Starbuck, C., Walsh, B.J. & Wiley, H.S. (1990). Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization. J. Biol. Chem. 265, 15713-15723.
13. Lemmon, M.A. & Schlessinger, J. (1994). Regulation of signal transduction and signal diversity by receptor oligimerization. Trends Biochem. Sci. 19, 459-463.
14. Van der Geer, P., Hunter, T. & Lindberg, R.A. (1994). Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10, 251-337.
15. Tadaki, D.K. & Niyogi, S.K. (1993). The functional importance of hydrophobicity of the tyrosine at position 13 of human epidermal growth factor in receptor binding. J. Biol. Chem. 268, 10114-10119.
16. Reddy, C.C., Niyogi, S.K., Wells, A., Wiley, H.S. & Lauffenburger, D.A. (1996). Engineering epidermal growth factor for enhanced mitogenic potency. Nat. Biotechnol. 14, 1696-1699.
17. French, A.R., Tadaki, D.K., Niyogi, S.K. & Lauffenburger, D.A. (1995). Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J. Biol. Chem. 270, 4334-4340.
18. French, A.R. (1995). Experimental and Modeling Studies of Endosomal Sorting Using the Epidermal Growth Factor/Receptor System in Fibroblasts. Ph.D. thesis, University of Illinois, Urbana, IL.
19. Wiley, H.S. (1988). Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system. J. Cell Biol. 107, 801-810.
20. Herbst, J.J., Opresko, L.K., Walsh, B.J., Lauffenburger, D.A. & Wiley, H.S. (1994). Regulation of postendocytic trafficking of the epidermal growth factor receptor through endosomal retention. J. Biol. Chem. 269, 12865-12873.
21. French, A.R., Sudlow, G.P., Wiley, H.S. & Lauffenburger, D.A. (1994). Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions. J. Biol. Chem. 269, 15749-15755.
22. Kurten, R.C., Cadena, D.L. & Gill, G.N. (1996). Enhanced degradation of EGF receptors by a sorting nexin, SNX1. Science 272, 1008-1010.
23. Ebner, R. & Derynck, R. (1991). Epidermal growth factor and transforming growth factor-α: differential intracellular routing and processing of ligand-receptor complexes. Cell Regulation 2, 599-612.
24. Reddy, C.C., Wells, A. & Lauffenburger, D.A. (1996). Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor a. J. Cell. Phys. 166, 512-522.
25. Reddy, C.C. (1996). Growth Factor-Induced Mitogenesis: Trafficking Determinants of the Cellular Response. Ph.D. thesis, University of Illinois, Urbana, IL.
26. Chang, C., et al., & Gill, G.N. (1993). Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors. J. Biol. Chem. 268, 19312-19320.
27. Lenferink, A.E.G., et al., & Yarden, Y. (1998). Differential endocytic routing of homo- and heterodimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers. EMBO J. 17, 3385-3397.
28. Baass, P.C., Di Guglielmo, G.M., Authier, F., Posner, B.I. & Bergeron, J.J.M. (1995). Compartmentalized signal transduction by receptor tyrosine kinases. Trends Cell Biol. 5, 465-470.
29. Worthylake, R. & Wiley, S.H. (1997). Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu. J. Biol. Chem. 272, 8594-8601.
30. Starbuck, C. & Lauffenburger, D.A. (1992). Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses. Biotech. Progr. 8, 132-143.
31. French, A.R. & Lauffenburger, D.A. (1996). Intracellular receptor/ligand sorting based on endosomal retention components. Biotech. Bioeng. 51, 281-297.
32. Haugh, J.M. & Lauffenburger, D.A. (1998). Analysis of receptor internalization as a mechanism for modulating signal transduction. J. Theor. Biol., in press.
33. Chen, P., Gupta, K. & Wells, A. (1994). Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J. Cell Biol. 124, 547-555.
34. Chen, P., Xie, H., Sekar, M.C, Gupta, K. & Wells, A. (1994). Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J. Cell Biol. 127, 847-857.
35. Taniguchi, T., Matsui, H., Fujitas, T., Tokaoka, C., Kashima, N., Yoshimoto, R. & Hamuro, J. (1983). Structure and expression of a cloned cDNA for human interleukin-2. Nature 302, 305-310.
36. Bazan, J.F. (1992). Unraveling the structure of IL-2. Science 257, 410-412.
37. Gillis, S., Ferm, M.M., Ou, W. & Smith, K.A. (1978). T-cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 121, 2027-2032.
38. Smith, K.A. (1988). Interleukin-2: inception, impact and implications. Science 240, 1169-1176.
39. Henny, C.S., Kuribayashi, K., Kern, D.R. & Gillis, S. (1981). Interleukin-2 augments natural killer cell activity. Nature 291, 335-338.
40. Lee, B. & Ciardelli, T.L. (1992). Clinical applications of cytokines for immunostimulation and immunosuppression. Prog. Drug Res. 39, 167-197.
41. Jung, L.K.L., Hara, R. & Fu, S.M. (1984). Detection and functional studies of -60-65 (Tac antigen) on activated human B cells. J. Exp. Med. 160, 1597-1602.
42. Waldmann, T.A., Goldman, C.K., Robb, R.J., Depper, J.M., Leonard, W.J., Sharrow, S.O., Bongiovanni, K.F., Korsmeyer, S.J. & Greene, W.C. (1984). Expression of interleukin-2 receptors on activated human B cells. J. Exp. Med. 160, 1450-66.
43. Gaulton, G.N. & Williamson, P. (1994). Interleukin-2 and the interleukin-2 receptor complex. Chem. Immunol. 59, 91-114.
44. Hatekeyama, M., Mori, H., Doi, T. & Taniguchi, T. (1989). A restricted cytoplasmic region of IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 59, 837-845.
45. Duprez, V., Ferrer, M., Cornet, V., Olive, D. & Dautry-Varsat, A. (1991). Modulation of interleukin 2 internalization and interleukin 2-dependent cell growth by antireceptor antibodies. J. Biol. Chem. 266, 1497-1501.
46. Asao, H., Takeshita, T., Ishii, N., Kumaki, S., Nakamura, M. & Sugamura, K. (1993). Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: involvement of the cytoplasmic domain of the γ chain in two distinct signaling pathways. Proc. Natl Acad. Sci. USA 90, 4127-4131.
47. Liu, K.D., Lai, S.Y., Goldsmith, M.A. & Greene, W.C. (1995). Identification of a variable region within the cytoplasmic tail of the IL-2 receptor β chain that is required for growth signal transduction. J. Biol. Chem. 270, 22176-22181.
48. Miyazaki, T., et al., & Taniguchi, T. (1995). Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81, 223-231.
49. Weissman, A.M., Harford, J.B., Svetlik, P.B., Leonard, W.L., Depper, J.M., Waldmann, T.A., Greene, W.C. & Klausner, R.D. (1986). Only high affinity receptors for interleukin-2 mediate internalization of ligand. Proc. Natl Acad. Sci. USA 83, 1463-1466.
50. Tanaka, T., Saiki, O., Doi, S., Fuji, M., Sugamura, K., Hara, H., Negoro, S. & Kishimoto, S. (1988). Novel receptor-mediated internalization of interleukin 2 in B cells. J. Immunol. 140, 866-870.
51. Fujii, M., Sugamura, K., Sano, K., Nakai, M., Sugita, K. & Hinuma, Y. (1986). High-affinity receptor-mediated internalization and degradation of interleukin-2 in human T cells. J. Exp. Med. 163, 550-562.
52. Gullberg, M. (1987), Analysis of dynamics and functions of high-affinity interleukin-2 receptors. Mol. Immunol. 24, 1365-1371.
53. Robb, R.J. & Greene, W.C. (1987). Internalization of interleukin-2 is mediated by the β chain of the high affinity interleukin-2 receptor. J. Exp. Med. 165, 1201-1206.
54. Duprez, V., Smoljanovic, M., Lieb, M. & Dautry-Varsat, A. (1994). Trafficking of interleukin 2 and transferrin in endosomal fractions of T lymphocytes. J. Cell Sci. 107, 1289-1295.
55. Hemar, A., Subtil, A., Lieb, M., Morelon, E., Hellio, R. & Dautry-Varsat, A. (1995). Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor α, β, and γ chains. J. Cell Biol. 129, 55-64.
56. Berndt, W.G., Chang, D.Z., Smith, K.A. & Ciardelli, T.L. (1994). Mutagenic analysis of a receptor contact site on interleukin-2: preparation of an IL-2 analog with increased potency. Biochemistry 33, 6571-6577.
57. Chang, D.Z., Tasayco, M.L. & Ciardelli, T.L. (1995). Structural analogs of interleukin-2: a point mutation that facilitates biological response. Mol. Pharm. 47, 206-211.
58. Chang, D.Z., Wu, Z. & Ciardelli, T.L. (1996). A point mutation in interleukin-2 that alters ligand internalization. J. Biol. Chem. 271, 13349-13355.